Acadia Pharmaceuticals (ACAD) FCF Margin (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly FCF Margin of 10.73% for Q1 2026, up 241.0% year-over-year from 3.15% in Q1 2025, and up 157.79% quarter-over-quarter from 18.57% in Q4 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) FCF Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' FCF Margin history runs 17 years deep, the most recent figure standing at 10.73% for Q1 2026.
- In Q1 2026, FCF Margin rose 241.0% year-over-year to 10.73%; the TTM figure through Mar 2026 stood at 10.37% (down 453.0% YoY), while the FY2025 annual figure was 9.81%, down 660.0% from the prior year.
- FCF Margin for Q1 2026 stood at 10.73%, up from 18.57% in the prior quarter.
- The five-year high for FCF Margin was 36.96% in Q4 2023, with the low at 66.1% in Q1 2022.
- The 5-year median for FCF Margin is 8.32% (2025), against an average of 1.25%.
- The sharpest annual moves came in 2023 and 2025: FCF Margin soared 5444 bps in 2023, then plunged 3395 bps in 2025.
- Acadia Pharmaceuticals' FCF Margin stood at 17.48% in 2022, then soared by 311 bps to 36.96% in 2023, then slumped by 58 bps to 15.38% in 2024, then slumped by 221 bps to 18.57% in 2025, then surged by 158 bps to 10.73% in 2026.
- Business Quant data shows ACAD's FCF Margin at 10.73% in Q1 2026, 18.57% in Q4 2025, and 26.52% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Acadia Pharmaceuticals | 4.82 Bn | 3.86 Bn | 279.64 Mn | 31.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.07% |
| Mar 31, 2026 | 10.73% |
| Dec 31, 2025 | -18.57% |
| Sep 30, 2025 | 26.52% |
| Jun 30, 2025 | 24.06% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 15.38% |
| Sep 30, 2024 | 25.23% |
| Jun 30, 2024 | 10.34% |
| Mar 31, 2024 | 14.13% |
| Dec 31, 2023 | 36.96% |
| Sep 30, 2023 | -27.85% |
| Jun 30, 2023 | 4.96% |
| Mar 31, 2023 | -15.14% |
| Dec 31, 2022 | -17.48% |
| Sep 30, 2022 | -0.56% |
| Jun 30, 2022 | -9.75% |
| Mar 31, 2022 | -66.10% |
| Dec 31, 2021 | -17.68% |
| Sep 30, 2021 | -12.97% |